+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oriola Corp (OKDBV) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 56 Pages
  • September 2024
  • GlobalData
  • ID: 5457454
Oriola Corp (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oriola Corp (Oriola) specializes in the wholesale and distribution of pharmaceuticals and healthcare products. Its primary operations include pharmaceutical logistics, dose dispensing services, and the wholesale of traded goods, over-the-counter (OTC) products, parallel import, and special licensed medicines. Oriola's product range includes health and wellbeing products. It offers vitamins, food and food supplements, sports nutrients, wound care and beauty and makeup products. The company also offers a selection of products such as wound care, bandage and support accessories, and medicine dispensers. Oriola's products are available through pharmacies, online pharmacy stores and grocery stores. The company primarily operates in the Finnish and Swedish markets. Oriola is headquartered in Espoo, Finland.

Oriola Corp Key Recent Developments

  • Aug 29, 2024: Oriola Names Mats Danielsson as Chief Financial Officer
  • Jul 18, 2024: Oriola Announces Half-Year Report for January-June 2024
  • Jul 04, 2024: Oriola to Publish Its Half-Year Report for January-June 2024 on 18 July 2024
  • Apr 25, 2024: Oriola Corporation’s Interim Report January-March 2024

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Oriola Corp - Key Facts
  • Oriola Corp - Key Employees
  • Oriola Corp - Key Employee Biographies
  • Oriola Corp - Major Products and Services
  • Oriola Corp - History
  • Oriola Corp - Company Statement
  • Oriola Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Oriola Corp - Business Description
  • Business Segment: Distibution
  • Overview
  • Performance
  • Business Segment: Wholesale
  • Overview
  • Performance
  • Geographical Segment: Finland
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • Geographical Segment: Sweden
  • Performance
  • Oriola Corp - Corporate Strategy
  • Oriola Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Oriola Corp - Strengths
  • Oriola Corp - Weaknesses
  • Oriola Corp - Opportunities
  • Oriola Corp - Threats
  • Oriola Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Oriola Corp, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Oriola Corp, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Oriola Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 29, 2024: Oriola Names Mats Danielsson as Chief Financial Officer
  • Jul 18, 2024: Oriola Announces Half-Year Report for January-June 2024
  • Jul 04, 2024: Oriola to Publish Its Half-Year Report for January-June 2024 on 18 July 2024
  • Apr 25, 2024: Oriola Corporation’s Interim Report January-March 2024
  • Apr 11, 2024: Oriola Oyj: Oriola Corporation to publish its Interim Report for January-March 2024 on 25 April 2024
  • Feb 27, 2024: Oriola Announces Annual Report 2023
  • Feb 16, 2024: Oriola Oyj: Notice to Oriola Corporation''s Annual General Meeting 2024
  • Feb 16, 2024: Oriola Financial Statements Release 1 January-31 December 2023
  • Feb 02, 2024: Oriola to publish its Financial Statements Release 2023 on 16 February 2024
  • Jan 24, 2024: Oriola Announces Proposals of the Shareholders' Nomination Board Concerning the Board of Directors to be Elected by the 2024 Annual General Meeting
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Oriola Corp, Key Facts
  • Oriola Corp, Key Employees
  • Oriola Corp, Key Employee Biographies
  • Oriola Corp, Major Products and Services
  • Oriola Corp, History
  • Oriola Corp, Subsidiaries
  • Oriola Corp, Joint Venture
  • Oriola Corp, Key Competitors
  • Oriola Corp, Ratios based on current share price
  • Oriola Corp, Annual Ratios
  • Oriola Corp, Interim Ratios
  • Oriola Corp, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Oriola Corp, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Oriola Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Oriola Corp, Performance Chart (2019 - 2023)
  • Oriola Corp, Ratio Charts
  • Oriola Corp, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Oriola Corp, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Entero Healthcare Solutions Ltd
  • Cencora Inc
  • Acorda Therapeutics Inc
  • Oral Hammaslaakarit Oyj
  • Raisio plc